🚨#BREAKING: A 28-year-old confirms he has spent the last 10 YEARS of his life interviewing World War II combat veterans to keep their stories alive...
...in fact, for the last 10 years, he has interviewed World War 2 veterans EVERY SINGLE DAY
He started as a teenager, ditching school to ride his BIKE to the local retirement home, walking up to the front desk and asking to, "meet some World War II heroes."
His name is Rishi Sharma.
He's crossed all 50 states and half the world.
He's slept in his car and lived on gas-station food to afford it.
He asks these men for hours of their memories, and then he hands the entire recording to their families...
...FOR FREE
So that 200 years from now, a great-great-grandchild will know not just their hero's name, but how he laughed, how he cried, and what he sacrificed.
Rishi has no military family, his parents immigrated here from India.
He does it out of pure gratitude.
In his words:
"My parents were given the opportunity to immigrate and raise a family because of veterans like these. It's a debt of love I'll spend my entire life trying to repay..."
As one 100-year-old Marine who stormed Iwo Jima told him, remembering the flag going up:
"The hair on my arms still stands up when I think about how beautiful it was."
THAT is America.
250 years of ordinary people doing extraordinary things...
God bless our veterans. 🇺🇸🇺🇸
@AnilMakam I suppose that analogy makes sense as medicine is practiced like thousands of varsity high school games happening simultaneously across the country, not a handful of Grand Slam matches.
Will be interesting to see what AI enables.
@withoutwaiver@MarkLevineNYC Super long term national data, which is good but probably not what we’re after here.
New York data specifically plus since the expansion of CDPAP to family members (last couple years). My understanding is the costs from that have gone wildly out of control.
Matched into diagnostic #radiology, my long-time dream speciality!! I’m so excited to see where I matched for residency on Friday! 🙏🏽🧿✨ #radres#match2025
@SPuro88@Elmo0201921412@CoffeeBlackMD I still understand your take too, however. But personally lean towards broadening the aperture just a bit for the right subset of non practicing folks so long as their shoulder deep in patient relevant work.
@Elmo0201921412@SPuro88@CoffeeBlackMD I don’t know about never saw a patient. You also run into the same question with pathologists who are arguably some of the most important clinician scientists advancing research the most.
Would you characterize pathologists at leading academic institutions as “not a clinician”?
Adam Liebers had a busy summer flying rocket, observing the sun, and researching on solar-terrestrial interactions under the supervision of Prof. Hava Turkakin. Adam’s research was supported by NSF-Magnetospheric Physics.
About 1 in 5 of us have an APOE4 gene variant, the #1 genetic risk factor for Alzheimer's disease. But the mechanism for brain injury was a mystery, now getting unraveled (cholesterol processing by oligodendrocytes) https://t.co/gIpGt0CA28
@nature
https://t.co/hbmdpO6R3t
@wolfejosh Big step forward.
Have seen some apheresis clinics evolve dramatically over the past several years (from legacy focus like SS treatment to now majority T cell harvesting on any given day).
Interesting to think of the infrastructure/services at play in a T-cell future.
Pleased to report the findings of the PROFOUND study ctDNA analysis. Great team effort! Matsubara et al.
🧬ctDNA testing may be a viable option for identifying individuals with mCRPC who have BRCA/ATM alterations and may benefit from olaparib.
@CCR_AACR@OncoAlert@PCF_Science